Pirro, Federico
 Distribuzione geografica
Continente #
NA - Nord America 226
EU - Europa 187
AS - Asia 24
AF - Africa 4
SA - Sud America 3
Totale 444
Nazione #
US - Stati Uniti d'America 225
IT - Italia 67
SE - Svezia 44
DE - Germania 24
IE - Irlanda 20
TH - Thailandia 8
ES - Italia 6
FR - Francia 6
JP - Giappone 6
CI - Costa d'Avorio 4
GR - Grecia 4
CN - Cina 3
GB - Regno Unito 3
TW - Taiwan 3
BE - Belgio 2
BR - Brasile 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
KR - Corea 2
PT - Portogallo 2
SI - Slovenia 2
AR - Argentina 1
CA - Canada 1
HR - Croazia 1
IN - India 1
IR - Iran 1
RO - Romania 1
RU - Federazione Russa 1
Totale 444
Città #
Chandler 89
Ashburn 20
Dublin 20
Milan 14
New York 11
Bremen 10
Boston 9
Princeton 9
Rome 9
Chiang Mai 8
Frankfurt am Main 8
Paris 6
Abidjan 4
San Mateo 4
Cinisello Balsamo 3
Hot Springs 3
Taichung 3
Athens 2
Barcelona 2
Beijing 2
Brno 2
Brussels 2
Cagliari 2
Comiso 2
Gangnam-gu 2
Ig 2
Lisbon 2
Madrid 2
Munich 2
Old Faliron 2
Padova 2
Santa Coloma de Gramenet 2
Stockholm 2
Terni 2
Wilmington 2
Yokohama 2
Zurich 2
Alcamo 1
Atlanta 1
Bologna 1
Bucharest 1
Buenos Aires 1
Busto Arsizio 1
Campobasso 1
Carrara 1
Carugate 1
Chicago 1
Chions 1
Decimomannu 1
Denver 1
Florence 1
Genoa 1
Greenwich 1
Jacksonville 1
Kagoshima 1
Leawood 1
New Bedfont 1
Norwalk 1
Osaka 1
Parrano 1
Pioltello 1
Porto Alegre 1
Pune 1
Redwood City 1
Rimini 1
Rio de Janeiro 1
San Gregorio di Catania 1
Santa Maria di Licodia 1
Seattle 1
Southwark 1
Split 1
Tappahannock 1
Tokyo 1
Valverde 1
Vancouver 1
Vicenza 1
Washington 1
Zhengzhou 1
Ōtsu 1
Totale 312
Nome #
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study 131
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature 45
New JAK inhibitors for the treatment of psoriasis and psoriatic arthritis 42
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy 40
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice 37
Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study 34
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 29
A case of guttate psoriasis during treatment with dupilumab 26
Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study 25
Multiple paradoxical reactions during ixekizumab therapy 20
The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies 14
Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study 11
Totale 454
Categoria #
all - tutte 2.350
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.350


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 5 3 1 1 2
2021/202232 0 0 0 2 2 0 0 4 2 0 11 11
2022/2023296 17 37 12 66 32 28 4 27 41 2 16 14
2023/2024114 10 31 13 14 12 12 9 5 2 6 0 0
Totale 454